Title
Sedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort
Date Issued
17 April 2019
Access level
open access
Resource Type
journal article
Author(s)
Aragón R.E.
Mongilardi N.
De Ferrari A.
Herrera P.
Paz E.
Jaymez A.A.
Chirinos E.
Portugal J.
Quispe R.
Brower R.G.
Checkley W.
Publisher(s)
BioMed Central Ltd.
Abstract
Objectives: We sought to study the association between sedation status, medications (benzodiazepines, opioids, and antipsychotics), and clinical outcomes in a resource-limited setting. Design: A longitudinal study of critically ill participants on mechanical ventilation. Setting: Five intensive care units (ICUs) in four public hospitals in Lima, Peru. Patients: One thousand six hundred fifty-seven critically ill participants were assessed daily for sedation status during 28 days and vital status by day 90. Results: After excluding data of participants without a Richmond Agitation Sedation Scale score and without sedation, we followed 1338 (81%) participants longitudinally for 18,645 ICU days. Deep sedation was present in 98% of participants at some point of the study and in 12,942 ICU days. Deep sedation was associated with higher mortality (interquartile odds ratio (OR) = 5.42, 4.23-6.95; p < 0.001) and a significant decrease in ventilator (- 7.27; p < 0.001), ICU (- 4.38; p < 0.001), and hospital (- 7.00; p < 0.001) free days. Agitation was also associated with higher mortality (OR = 39.9, 6.53-243, p < 0.001). The most commonly used sedatives were opioids and benzodiazepines (9259 and 8453 patient days respectively), and the latter were associated with a 41% higher mortality in participants with a higher cumulative dose (75th vs 25th percentile, interquartile OR = 1.41, 1.12-1.77; p < 0.01). The overall cumulative dose of benzodiazepines and opioids was high, 774.5 mg and 16.8 g, respectively, by day 7 and by day 28; these doses approximately doubled. Haloperidol was only used in 3% of ICU days; however, the use of it was associated with a 70% lower mortality (interquartile OR = 0.3, 0.22-0.44, p < 0.001). Conclusions: Deep sedation, agitation, and cumulative dose of benzodiazepines were all independently associated with higher 90-day mortality. Additionally, deep sedation was associated with less ventilator-, ICU-, and hospital-free days. In contrast, haloperidol was associated with lower mortality in our study.
Volume
23
Issue
1
Language
English
OCDE Knowledge area
Cuidado crítico y de emergencia
Farmacología, Farmacia
Scopus EID
2-s2.0-85064409092
PubMed ID
Source
Critical Care
ISSN of the container
13648535
Sponsor(s)
This study was supported by a Pathway to Independence Award (R00HL096955) from the National Heart, Lung and Blood Institute, National Institutes of Health.
Sources of information:
Directorio de Producción Científica
Scopus